**Core Concept:** Oestrogen is a hormone that plays a crucial role in maintaining bone density, particularly in postmenopausal women. Tamoxifen is a selective estrogen receptor modulator (SERM) that acts as an antagonist at the oestrogen receptor in breast tissue and as an agonist at the oestrogen receptor in bone.

**Why the Correct Answer is Right:** Tamoxifen is primarily used to treat breast cancer, particularly in postmenopausal women. However, its long-term use raises concerns about its impact on bone health. Tamoxifen's dual action as an agonist at the oestrogen receptor in bone (promoting bone density) and antagonist at the oestrogen receptor in breast tissue (blocking oestrogen's stimulatory effect) can lead to an imbalance in oestrogen action.

**Why Each Wrong Option is Incorrect:**

A. Tamoxifen's antagonism at the oestrogen receptor in breast tissue is the primary mode of action in treating breast cancer. Thus, this option is incorrect because tamoxifen does have an inhibitory effect on breast cancer cells.

B. Tamoxifen's agonist effect at the oestrogen receptor in bone is a beneficial action, contributing to bone health. This option is incorrect because the overall effect of tamoxifen's dual action is not fully understood, and the antagonism in breast tissue may outweigh the agonist effect in bone.

C. Tamoxifen's antagonism in breast tissue and agonist effect in bone is the correct mode of action in treating breast cancer. This option is incorrect because the overall effect of tamoxifen's dual action is not fully understood, and the antagonism in breast tissue may outweigh the agonist effect in bone.

D. Tamoxifen's agonist effect in bone leads to increased bone density, thus preventing osteoporosis. This option is incorrect because the overall effect of tamoxifen's dual action is not fully understood, and the antagonism in breast tissue may outweigh the agonist effect in bone.

**Clinical Pearl:** While tamoxifen's agonist effect in bone is beneficial, the antagonism in breast tissue is the primary mode of action in treating breast cancer, and this may outweigh the agonist effect in bone, leading to a net detrimental effect on bone health.

**Correct Answer:** D. Tamoxifen increases bone resorption leading to an increased risk of osteoporosis in some patients.